Bayer plans to enter the market for wound-healing products. Bayer Innovation GmbH ? a subsidiary of Bayer AG ? has developed a leading-edge technology for the manufacture of bioresorbable wound dressings on the basis of silica gel fibers. A ceremony was held on May 4 in Leverkusen to mark the inauguration of a pilot plant which will manufacture the wound dressing in sufficient quantities to enable clinical trials to be carried out.
Advanced Cell Technology, Inc. (OTCBB: ACTC) reported for the first time that hemangioblast precursor cells derived from human embryonic stem (hES) cells can be used to achieve vascular repair. The research, which appears today online (ahead of print) in the journal Nature Methods, by Advanced Cell Technology (ACT) and its collaborators, describes an efficient method for generating large numbers of bipotential progenitors–known as hemangioblasts–from hES cells that are capable of differentiating into blood vessels, as well as into all blood and immune cell lineages.
Today, nearly 40 of the US’s top business leaders and largest employers joined forces to announce the formation of the Coalition to Advance Healthcare Reform (CAHR). Standing shoulder to shoulder with lawmakers at a Capitol Hill press conference, they discussed the coalition’s core principles, its mission and called for meaningful federal and state policy reforms by 2009 to solve the nation’s healthcare crisis.
First-time dads have typically been a little short-changed when it comes to the resources available for improving their parenting skills. Moms have far more options and, where there are programs for dads, they’re often based on a model that works for women.
A widely used diabetes drug dramatically boosted the potency of platinum-based cancer drugs when administered together to a variety of cancer cell lines and to mice with tumors, scientists from Dana-Farber Cancer Institute report.
In a study that could point to novel therapies to prevent cancer spread, or metastasis, researchers at the University of California, San Diego, School of Medicine have targeted a sugar that supports blood vessel growth in the tumor. Their findings will be published in the May 7 online issue of Journal of Cell Biology.
Professor Andrew Boulton and his team used green bottle fly larvae to treat 13 diabetic patients whose foot ulcers were contaminated with MRSA and found all but one were cured within a mean period of three weeks, much quicker than the 28-week duration for the conventional treatment.
Hamilton College researchers have identified molecules that have been shown to be effective in the fight against breast cancer. The Hamilton researchers used state-of-the-art computational techniques in a novel way to design molecules that they predicted would be effective lead compounds for breast cancer research.
University of Manchester researchers are ridding diabetic patients of the superbug MRSA – by treating their foot ulcers with maggots.
A combination of three different drugs that block the HER-2 receptor, a critical cellular growth signal for some breast cancers, eradicated aggressive breast tumors in mice and could point the way toward developing better treatments in patients, said researchers from the Breast Center at Baylor College of Medicine in a report that appears today in the Journal of the National Cancer Institute.